Zobrazeno 1 - 10
of 107
pro vyhledávání: '"A V, Susekov"'
Autor:
Andrey V. Susekov
Publikováno v:
Consilium Medicum, Vol 26, Iss 10, Pp 641-648 (2024)
Statins have been used in clinical practice for more than 40 years to treat and prevent atherosclerosis and its complications. The results of observational studies indicate that, despite a large evidence base, statins in Russia are still prescribed i
Externí odkaz:
https://doaj.org/article/20ccb4c597724b3d9e13391b02d9b130
Autor:
Andrey V. Susekov
Publikováno v:
Consilium Medicum, Vol 24, Iss 1, Pp 20-27 (2022)
Hypercholesterolemia (high levels of atherogenic lipoproteins) is the main modifiable cardiovascular risk factor in most of the populations, including the Russian population. 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (stati
Externí odkaz:
https://doaj.org/article/19a4d636f62642b0bb1b7d1a05ea28bc
Autor:
Andrey V. Susekov, Balakhonova T.V., Vladislav M. Soloviev, Yuliia S. Isaeva, Irina M. Miklashevich, Irina V. Leontieva
Publikováno v:
Клинический разбор в общей медицине, Vol 1, Iss 1, Pp 35-41 (2020)
Homozygous familial hypercholesterolemia is a severe genetic disorder characterized by extremely high levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C), as well as by rapid atherosclerosis progression in various vascular ter
Externí odkaz:
https://doaj.org/article/2a06db6d263042fb9ef0f2705be4e7ca
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 11 (2021)
Rhabdomyolysis is a very rare and most severe form of statin-induced muscle adverse event characterized by muscle pain, muscle necrosis with myoglobinemia and/or myoglobinuria with a very high risk of acute kidney injury and death. The article presen
Externí odkaz:
https://doaj.org/article/2c2e5f97eefb4b1aae1def2c6bb65e1c
Autor:
Jean-Charles Fruchart, Raul D. Santos, Carlos Aguilar-Salinas, Masanori Aikawa, Khalid Al Rasadi, Pierre Amarenco, Philip J. Barter, Richard Ceska, Alberto Corsini, Jean-Pierre Després, Patrick Duriez, Robert H. Eckel, Marat V. Ezhov, Michel Farnier, Henry N. Ginsberg, Michel P. Hermans, Shun Ishibashi, Fredrik Karpe, Tatsuhiko Kodama, Wolfgang Koenig, Michel Krempf, Soo Lim, Alberto J. Lorenzatti, Ruth McPherson, Jesus Millan Nuñez-Cortes, Børge G. Nordestgaard, Hisao Ogawa, Chris J. Packard, Jorge Plutzky, Carlos I. Ponte-Negretti, Aruna Pradhan, Kausik K. Ray, Željko Reiner, Paul M. Ridker, Massimiliano Ruscica, Shaukat Sadikot, Hitoshi Shimano, Piyamitr Sritara, Jane K. Stock, Ta-Chen Su, Andrey V. Susekov, André Tartar, Marja-Riitta Taskinen, Alexander Tenenbaum, Lale S. Tokgözoğlu, Brian Tomlinson, Anne Tybjærg-Hansen, Paul Valensi, Michal Vrablík, Walter Wahli, Gerald F. Watts, Shizuya Yamashita, Koutaro Yokote, Alberto Zambon, Peter Libby
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-20 (2019)
Abstract In the era of precision medicine, treatments that target specific modifiable characteristics of high-risk patients have the potential to lower further the residual risk of atherosclerotic cardiovascular events. Correction of atherogenic dysl
Externí odkaz:
https://doaj.org/article/6f4201f8fd5540cfabc2d78a10d3be4d
Autor:
Tannaz Jamialahmadi, Fatemeh Baratzadeh, Željko Reiner, Luis E. Simental-Mendía, Suowen Xu, Andrey V. Susekov, Raul D. Santos, Amirhossein Sahebkar
Publikováno v:
Mediators of Inflammation, Vol 2021 (2021)
Background. Elevated plasma low-density lipoprotein cholesterol (LDL-C) is the main risk factor for atherosclerotic cardiovascular disease (ASCVD). Statins are the drugs of choice for decreasing LDL-C and are used for the prevention and management of
Externí odkaz:
https://doaj.org/article/feee0207039a4f40af1acbbc173ec34d
Publikováno v:
Медицинский совет, Vol 0, Iss 17, Pp 253-260 (2018)
Homozygous familial hypercholesterolemia is a rare genetic disease featuring extremely high of low-density lipoprotein blood level, cutaneous and tendon xanthomas and accelerated atherosclerosis with often manifestions in the first 2 decades of life,
Externí odkaz:
https://doaj.org/article/ea149d6de65d4c53b98458063ed88a23
Autor:
N. M. Achmegdanov, S. A. Butrusova, I. I. Dedov, L. A. Zvenigorodskaya, O. A. Kislyak, O. A. Koshelskaya, I. V. Kuznecova, V. V. Kuharchuk, A. Yu. Litvin, I. V. Medvedeva, A. M. Mkrtumyan, V. B. Mychka, D. V. Nebieridze, S. V. Nedogoda, R. G. Oganov, M. Yu. Ogarkov, N. B. Perepech, V. I. Podzolkov, V. P. Smetnik, A. V. Susekov, V. N. Titov, T. V. Tyurina, A. N. Fursov, V. N. Hirmanov, I. E. Chazova, I. I. Chukaeva, M. V. Shestakova, A. T. Shubina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 6, Iss 4, Pp 599-606 (2016)
Russian Experts’ Consensus on Metabolic Syndrome Problem in the Russian Federation: Defenition, Diagnosis Criteria, Primary Prevention and Treatment.
Externí odkaz:
https://doaj.org/article/b0d7c7c4bf1f43db936192ee633a9513
Autor:
A. V. Susekov, N. V. Khokhlova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 7, Iss 2, Pp 231-240 (2016)
The evidences for statin use in cardiology are presented. Especially hypolipidemic efficacy of atorvastatin is demonstrated in according to comparative studies. Results of clinical studies on atorvastatin efficacy and safety in different groups of pa
Externí odkaz:
https://doaj.org/article/9a132f9ec51f4fb2b37baf5f8a8dd41a
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 6, Iss 3, Pp 345-348 (2016)
Aim. To evaluate quality of life changes and compliance to therapy in patients following successful transluminal angioplasty, who have indications for fluvastatin extended release in addition to standard treatment.Material and methods. This is a nati
Externí odkaz:
https://doaj.org/article/398ffab68877478e8e952cdab3611412